ArticleHaematologica2013

A novel orally available inhibitor of focal adhesion signaling increases survival in a xenograft model of diffuse large B-cell lymphoma with central nervous system involvement.

Rosa Bosch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.